"Designing Growth Strategies is in our DNA"

Opioid Use Disorder (OUD) Market Size, Share & Industry Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Stores, and Online Pharmacies), and Regional Forecast, 2025-2032

Last Updated: April 14, 2025 | Format: PDF | Report ID: FBI102674

 

Opioid Use Disorder (OUD) Market

Request Now
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Pipeline Analysis, Key Products
    2. New Product Launches
    3. Statistics of Opioid Use Disorder by Key Countries/Region
    4. Industry Developments Such as Mergers, Acquisitions, and Collaborations
    5. Impact of COVID-19 on Opioid Use Disorder (OUD) Market
  5. Global Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Buprenorphine
      2. Methadone
      3. Naltrexone
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Global Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Buprenorphine
      2. Methadone
      3. Naltrexone
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Global Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Buprenorphine
      2. Methadone
      3. Naltrexone
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Global Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Buprenorphine
      2. Methadone
      3. Naltrexone
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Rest of the World Global Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Buprenorphine
      2. Methadone
      3. Naltrexone
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
  10. Competitive Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
      1. Indivior PLC
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      2. Alkermes
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      3. Orexo US, Inc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      4. Titan Pharmaceuticals Inc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      5. Mallinckrodt
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      6. BioDelivery Sciences International Inc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      7. Viatris (Mylan N.V.)
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      8. Hikma Pharmaceuticals
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      9. Camurus
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      10. Braeburn Inc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
Read Less

Figure 1: Global Opioid Use Disorder (OUD) Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2032

Figure 2: Global Opioid Use Disorder (OUD) Market Value Share (%), by Drug Class, 2025 & 2032

Figure 3: Global Opioid Use Disorder (OUD) Market Value Share (%), by Route of Administration, 2025 & 2032

Figure 4: Global Opioid Use Disorder (OUD) Market Value Share (%), by Distribution Channel, 2025 & 2032

Figure 5: Global Opioid Use Disorder (OUD) Market Value (USD billion), by Region, 2025 & 2032

Figure 6: North America Opioid Use Disorder (OUD) Market Value (USD billion), by Drug Class, 2025 & 2032

Figure 7: North America Opioid Use Disorder (OUD) Market Value Share (%), by Drug Class, 2023

Figure 8: North America Opioid Use Disorder (OUD) Market Value (USD billion), by Route of Administration, 2025 & 2032

Figure 9: North America Opioid Use Disorder (OUD) Market Value Share (%), by Route of Administration, 2023

Figure 10: North America Opioid Use Disorder (OUD) Market Value (USD billion), by Distribution Channel, 2025 & 2032

Figure 11: North America Opioid Use Disorder (OUD) Market Value Share (%), by Distribution Channel, 2023

Figure 12: North America Opioid Use Disorder (OUD) Market Value (USD billion), By Country, 2025 & 2032

Figure 13: North America Opioid Use Disorder (OUD) Market Value Share (%), By Country, 2023

Figure 14: Europe Opioid Use Disorder (OUD) Market Value (USD billion), by Drug Class, 2025 & 2032

Figure 15: Europe Opioid Use Disorder (OUD) Market Value Share (%), by Drug Class, 2023

Figure 16: Europe Opioid Use Disorder (OUD) Market Value (USD billion), by Route of Administration, 2025 & 2032

Figure 17: Europe Opioid Use Disorder (OUD) Market Value Share (%), by Route of Administration, 2023

Figure 18: Europe Opioid Use Disorder (OUD) Market Value (USD billion), by Distribution Channel, 2025 & 2032

Figure 19: Europe Opioid Use Disorder (OUD) Market Value Share (%), by Distribution Channel, 2023

Figure 20: Europe Opioid Use Disorder (OUD) Market Value (USD billion), By Country/ Sub-region, 2025 & 2032

Figure 21: Europe Opioid Use Disorder (OUD) Market Value Share (%), By Country/ Sub-region, 2023

Figure 22: Asia Pacific Opioid Use Disorder (OUD) Market Value (USD billion), by Drug Class, 2025 & 2032

Figure 23: Asia Pacific Opioid Use Disorder (OUD) Market Value Share (%), by Drug Class, 2023

Figure 24: Asia Pacific Opioid Use Disorder (OUD) Market Value (USD billion), by Route of Administration, 2025 & 2032

Figure 25: Asia Pacific Opioid Use Disorder (OUD) Market Value Share (%), by Route of Administration, 2023

Figure 26: Asia Pacific Opioid Use Disorder (OUD) Market Value (USD billion), by Distribution Channel, 2025 & 2032

Figure 27: Asia Pacific Opioid Use Disorder (OUD) Market Value Share (%), by Distribution Channel, 2023

Figure 28: Asia Pacific Opioid Use Disorder (OUD) Market Value (USD billion), By Country/ Sub-region, 2025 & 2032

Figure 29: Asia Pacific Opioid Use Disorder (OUD) Market Value Share (%), By Country/ Sub-region, 2023

Figure 30: Rest of the World Opioid Use Disorder (OUD) Market Value (USD billion), by Drug Class, 2025 & 2032

Figure 31: Rest of the World Opioid Use Disorder (OUD) Market Value Share (%), by Drug Class, 2023

Figure 32: Rest of the World Opioid Use Disorder (OUD) Market Value (USD billion), by Route of Administration, 2025 & 2032

Figure 33: Rest of the World Opioid Use Disorder (OUD) Market Value Share (%), by Route of Administration, 2023

Figure 34: Rest of the World Opioid Use Disorder (OUD) Market Value (USD billion), by Distribution Channel, 2025 & 2032

Figure 35: Rest of the World Opioid Use Disorder (OUD) Market Value Share (%), by Distribution Channel, 2023

Figure 36: Global Opioid Use Disorder (OUD) Market Share (%), By Company, 2023

Table 1: Global Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Drug Class, 2019–2032

Table 2: Global Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 3: Global Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 4: Global Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 5: North America Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 6: North America Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 7: North America Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 8: North America Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 9: Europe Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 10: Europe Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 11: Europe Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 12: Europe Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 13: Asia Pacific Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 14: Asia Pacific Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 15: Asia Pacific Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 16: Asia Pacific Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 17: Rest of the World Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 18: Rest of the World Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 19: Rest of the World Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Opioid Use Disorder (OUD) Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2024
  • 2019-2023
  • 129
Consulting Services
    How will you benefit from our consulting services ?